PowerShow.com
  • Help
  • Preferences
  • Sign up
  • Log in
Advanced
Free template

Prasugrel PowerPoint PPT Presentations

Grid List
All Time
All TimeAdded TodayAdded This WeekAdded This Month
Show:
Recommended
RecommendedRelevanceLatestHighest RatedMost Viewed
Sort by:
Featured Presentations
Search Results
Prasugrel slide kit PowerPoint PPT Presentation
Prasugrel slide kit - NEJM TRITON MANUSCRIPT SLIDE KIT ... Dr Fran ois PHILIPPE Institut Mutualiste Montsouris Paris
NEJM TRITON MANUSCRIPT SLIDE KIT ... Dr Fran ois PHILIPPE Institut Mutualiste Montsouris Paris
| PowerPoint PPT presentation | free to view
Formulary Review: Prasugrel (Effient  PowerPoint PPT Presentation
Formulary Review: Prasugrel (Effient - Pharmaceutics and Therapeutics Committee Spring, 2011 Abby Stoddard Sarah Shore Justine Meierhofer Caitlin Wilke * * * * * * * * * * * * * * * * * * * * * * * * * * * ...
Pharmaceutics and Therapeutics Committee Spring, 2011 Abby Stoddard Sarah Shore Justine Meierhofer Caitlin Wilke * * * * * * * * * * * * * * * * * * * * * * * * * * * ...
| PowerPoint PPT presentation | free to view
TRITONTIMI 38 and PRINCIPLETIMI 44 Trials of Prasugrel PowerPoint PPT Presentation
TRITONTIMI 38 and PRINCIPLETIMI 44 Trials of Prasugrel - TRITON-TIMI 38 and PRINCIPLE-TIMI 44 Trials of Prasugrel. Stephen ... TRITON TIMI 38 tested the hypothesis that an agent with ... TRITON TIMI 38 Balance of ...
TRITON-TIMI 38 and PRINCIPLE-TIMI 44 Trials of Prasugrel. Stephen ... TRITON TIMI 38 tested the hypothesis that an agent with ... TRITON TIMI 38 Balance of ...
| PowerPoint PPT presentation | free to view
TRial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet InhibitioN with Prasugrel PowerPoint PPT Presentation
TRial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet InhibitioN with Prasugrel - Title: PowerPoint Presentation Author: Elliott Antman Last modified by: Timi Study Created Date: 9/23/2007 6:31:47 PM Document presentation format
Title: PowerPoint Presentation Author: Elliott Antman Last modified by: Timi Study Created Date: 9/23/2007 6:31:47 PM Document presentation format
| PowerPoint PPT presentation | free to view
TRial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet InhibitioN with Prasugrel PowerPoint PPT Presentation
TRial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet InhibitioN with Prasugrel - Title: PowerPoint Presentation Author: Elliott Antman Last modified by: Elliott Antman Created Date: 9/23/2007 6:31:47 PM Document presentation format
Title: PowerPoint Presentation Author: Elliott Antman Last modified by: Elliott Antman Created Date: 9/23/2007 6:31:47 PM Document presentation format
| PowerPoint PPT presentation | free to view
TRial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet InhibitioN with Prasugrel PowerPoint PPT Presentation
TRial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet InhibitioN with Prasugrel - Anatomy. 0. 5. 10. 15. 0. 30. 60. 90. 180. 270. 360. 450 ... Male. STEMI. UA/NSTEMI. 0.5. 1. 2. Prasugrel Better. Clopidogrel Better. HR. Age. Reduction in risk ...
Anatomy. 0. 5. 10. 15. 0. 30. 60. 90. 180. 270. 360. 450 ... Male. STEMI. UA/NSTEMI. 0.5. 1. 2. Prasugrel Better. Clopidogrel Better. HR. Age. Reduction in risk ...
| PowerPoint PPT presentation | free to view
Generic Prasugrel Effient Medication Lowest Cost
Generic Prasugrel Effient Medication Lowest Cost - Generic Prasugrel Effient comes in 5mg and 10mg in Tablet form. In the Market, this medication is available in Generic and Brand. If anyone wants to buy this medicine at the lowest cost guaranteed then they can write at WeCare@GenuineDrugs123.com. This Team will help them to get these meds at their doorstep within few working days globally. For more information about these pills as – Dosage, Uses, Side effects, Warnings, Missed dose, Overdose, etc., visit at https://bit.ly/3oOv6dn
Generic Prasugrel Effient comes in 5mg and 10mg in Tablet form. In the Market, this medication is available in Generic and Brand. If anyone wants to buy this medicine at the lowest cost guaranteed then they can write at WeCare@GenuineDrugs123.com. This Team will help them to get these meds at their doorstep within few working days globally. For more information about these pills as – Dosage, Uses, Side effects, Warnings, Missed dose, Overdose, etc., visit at https://bit.ly/3oOv6dn
Prasugrel Compared to Clopidogrel in Patients with Acute Coronary Syndromes Undergoing PCI with Sten PowerPoint PPT Presentation
Prasugrel Compared to Clopidogrel in Patients with Acute Coronary Syndromes Undergoing PCI with Sten - Prasugrel Compared to Clopidogrel in Patients with Acute Coronary Syndromes Undergoing PCI with Sten
Prasugrel Compared to Clopidogrel in Patients with Acute Coronary Syndromes Undergoing PCI with Sten
| PowerPoint PPT presentation | free to view
PRasugrel IN Comparison to clopidogrel for Inhibition of PLatelet activation and aggrEgation PRINCIP PowerPoint PPT Presentation
PRasugrel IN Comparison to clopidogrel for Inhibition of PLatelet activation and aggrEgation PRINCIP - Baseline laboratory measures. Prasugrel. 60 mg. Clopidogrel. 600 mg. 0.5 h post-loading dose labs ... Difference between treatments: 14.9 [95% CI, 10.6 19.3] ...
Baseline laboratory measures. Prasugrel. 60 mg. Clopidogrel. 600 mg. 0.5 h post-loading dose labs ... Difference between treatments: 14.9 [95% CI, 10.6 19.3] ...
| PowerPoint PPT presentation | free to download
Prasugrel Compared with Clopidogrel in Patients with ST-Elevation MI Undergoing Percutaneous Coronary Intervention PowerPoint PPT Presentation
Prasugrel Compared with Clopidogrel in Patients with ST-Elevation MI Undergoing Percutaneous Coronary Intervention - Prasugrel Compared with Clopidogrel in Patients with ST-Elevation MI Undergoing Percutaneous Coronary Intervention Gilles Montalescot, Stephen D. Wiviott, Eugene ...
Prasugrel Compared with Clopidogrel in Patients with ST-Elevation MI Undergoing Percutaneous Coronary Intervention Gilles Montalescot, Stephen D. Wiviott, Eugene ...
| PowerPoint PPT presentation | free to view
Prasugrel Compared to Clopidogrel in Patients with Acute Coronary Syndromes Undergoing PCI with Sten PowerPoint PPT Presentation
Prasugrel Compared to Clopidogrel in Patients with Acute Coronary Syndromes Undergoing PCI with Sten - Duration of therapy: 6-15 months. N= 13,608. Wiviott SD, Antman EM et al AHJ 2006. STENT ANALYSIS ... 844 patients with at least one stent as part of the index ...
Duration of therapy: 6-15 months. N= 13,608. Wiviott SD, Antman EM et al AHJ 2006. STENT ANALYSIS ... 844 patients with at least one stent as part of the index ...
| PowerPoint PPT presentation | free to view
Comparing ticagrelor versus prasugrel for the treatment of patients with acute coronary syndromes: evidence from a 32,983-patient adjusted indirect comparison meta-analysis PowerPoint PPT Presentation
Comparing ticagrelor versus prasugrel for the treatment of patients with acute coronary syndromes: evidence from a 32,983-patient adjusted indirect comparison meta-analysis - Dual antiplatelet therapy with aspirin and clopidogrel is effective and safe in patients with acute coronary syndromes (ACS).
Dual antiplatelet therapy with aspirin and clopidogrel is effective and safe in patients with acute coronary syndromes (ACS).
| PowerPoint PPT presentation | free to download
Diapositiva 1 PowerPoint PPT Presentation
Diapositiva 1 - * * * * * * The randomized double-blind TRITON-TIMI 38 trial showed that prasugrel was superior to clopidogrel in reducing ischemic events in patients with acute ...
* * * * * * The randomized double-blind TRITON-TIMI 38 trial showed that prasugrel was superior to clopidogrel in reducing ischemic events in patients with acute ...
| PowerPoint PPT presentation | free to download
Regione : Emilia-Romagna           Novita PowerPoint PPT Presentation
Regione : Emilia-Romagna Novita - NOVITA PRASUGREL : NUOVO PIANO TERAPEUTICO La Commissione Tecnico Scientifica dell Agenzia Italiana del Farmaco, nella seduta del 6/7 marzo 2012, ha deliberato ...
NOVITA PRASUGREL : NUOVO PIANO TERAPEUTICO La Commissione Tecnico Scientifica dell Agenzia Italiana del Farmaco, nella seduta del 6/7 marzo 2012, ha deliberato ...
| PowerPoint PPT presentation | free to download
TRITON-TIMI 38 PowerPoint PPT Presentation
TRITON-TIMI 38 - TRITON-TIMI 38 Trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial
TRITON-TIMI 38 Trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial
| PowerPoint PPT presentation | free to download
Plavix PowerPoint PPT Presentation
Plavix - PRASUGREL REDUCED THE RATE OF THE PRIMARY ENDPOINT IN DIABETIC PATIENST FROM 17% with clopidogrel to 12.2% of prasugrel patients. 68 events were prevented. There ...
PRASUGREL REDUCED THE RATE OF THE PRIMARY ENDPOINT IN DIABETIC PATIENST FROM 17% with clopidogrel to 12.2% of prasugrel patients. 68 events were prevented. There ...
| PowerPoint PPT presentation | free to download
On behalf of the TRILOGY ACS Investigators PowerPoint PPT Presentation
On behalf of the TRILOGY ACS Investigators - Prasugrel versus clopidogrel for patients with unstable angina/non-ST-segment elevation myocardial infarction who are medically managed after angiographic triage
Prasugrel versus clopidogrel for patients with unstable angina/non-ST-segment elevation myocardial infarction who are medically managed after angiographic triage
| PowerPoint PPT presentation | free to download
Coronary Heart Disease PowerPoint PPT Presentation
Coronary Heart Disease - ... prasugrel and ticagrelor Approved by SMC Place in therapy not clear May be alternative to clopidogrel as part of dual antiplatelet therapy Some benefits over ...
... prasugrel and ticagrelor Approved by SMC Place in therapy not clear May be alternative to clopidogrel as part of dual antiplatelet therapy Some benefits over ...
| PowerPoint PPT presentation | free to view
Advanced Cardiovascular Intervention 2009 PowerPoint PPT Presentation
Advanced Cardiovascular Intervention 2009 - PCI 40% stents
PCI 40% stents
| PowerPoint PPT presentation | free to download
Learning Objectives PowerPoint PPT Presentation
Learning Objectives - ... Ticagrelor vs Prasugrel PLATO Primary Efficacy End Point: CV Death, MI, or Stroke PLATO: Bleeding TRA-CER Primary End Point: CV Death, MI, Stroke, ...
... Ticagrelor vs Prasugrel PLATO Primary Efficacy End Point: CV Death, MI, or Stroke PLATO: Bleeding TRA-CER Primary End Point: CV Death, MI, Stroke, ...
| PowerPoint PPT presentation | free to download
A CME-CERTIFIED GRAND ROUNDS PROGRAM PowerPoint PPT Presentation
A CME-CERTIFIED GRAND ROUNDS PROGRAM - Prasugrel 60 mg should be given as soon as possible for primary PCI. MODIFIED Recommendation. Anderson JL et al. Circulation. 2007;116:803-877. O Connor JE et al.
Prasugrel 60 mg should be given as soon as possible for primary PCI. MODIFIED Recommendation. Anderson JL et al. Circulation. 2007;116:803-877. O Connor JE et al.
| PowerPoint PPT presentation | free to view
Interacci PowerPoint PPT Presentation
Interacci - Clopidogrel o Prasugrel: STEMI en que se prevee PCI primaria (1) Clopi en: - PCI no ... Dos cartas seguidas en Farm Hosp. Adendas a la revisiones en AJHSP ...
Clopidogrel o Prasugrel: STEMI en que se prevee PCI primaria (1) Clopi en: - PCI no ... Dos cartas seguidas en Farm Hosp. Adendas a la revisiones en AJHSP ...
| PowerPoint PPT presentation | free to download
Emerging Antiplatelet Therapies and the Latest Clinical Trials PowerPoint PPT Presentation
Emerging Antiplatelet Therapies and the Latest Clinical Trials - Patients will be randomized to either prasugrel or standard doses of clopidogrel. Patients will be followed on mantenance therapy for a median of 12 months.
Patients will be randomized to either prasugrel or standard doses of clopidogrel. Patients will be followed on mantenance therapy for a median of 12 months.
| PowerPoint PPT presentation | free to download
STUDY DESIGN PowerPoint PPT Presentation
STUDY DESIGN - STUDY DESIGN ACS (STEMI or UA/NSTEMI) & Planned PCI N= 13,000 ASA Double-blind CLOPIDOGREL 300 mg LD/ 75 mg MD PRASUGREL 60 mg LD/ 10 mg MD Median duration of therapy ...
STUDY DESIGN ACS (STEMI or UA/NSTEMI) & Planned PCI N= 13,000 ASA Double-blind CLOPIDOGREL 300 mg LD/ 75 mg MD PRASUGREL 60 mg LD/ 10 mg MD Median duration of therapy ...
| PowerPoint PPT presentation | free to download
Major Efficacy End Points in the PowerPoint PPT Presentation
Major Efficacy End Points in the - Title: Slide 1 Created Date: 11/14/2008 7:05:42 PM Document presentation format: On-screen Show (4:3) Other titles: Calibri Arial Times New Roman Office Theme Slide 1
Title: Slide 1 Created Date: 11/14/2008 7:05:42 PM Document presentation format: On-screen Show (4:3) Other titles: Calibri Arial Times New Roman Office Theme Slide 1
| PowerPoint PPT presentation | free to download
Assessment of the primary endpoint at 1 year (minimal FU of 6 months for the last patients) PowerPoint PPT Presentation
Assessment of the primary endpoint at 1 year (minimal FU of 6 months for the last patients) - ontinuation of double antiplatelet therapy one year after . stenting. ... of oral antiplatelet treatment in suboptimal responders. VASP @ day 1 and before discharge.
ontinuation of double antiplatelet therapy one year after . stenting. ... of oral antiplatelet treatment in suboptimal responders. VASP @ day 1 and before discharge.
| PowerPoint PPT presentation | free to download
Regione : Emilia-Romagna           Novita PowerPoint PPT Presentation
Regione : Emilia-Romagna Novita - EMILIA ROMAGNA : TICAGRELOR INSERITO IN PTOR La commissione regionale del farmaco della regione Emilia Romagna ha inserito il ticagrelor in ptor .
EMILIA ROMAGNA : TICAGRELOR INSERITO IN PTOR La commissione regionale del farmaco della regione Emilia Romagna ha inserito il ticagrelor in ptor .
| PowerPoint PPT presentation | free to download
 PowerPoint PPT Presentation
- Cu les son las limitaciones de los nuevos antiagregantes? However, if we look at non CABG bleeding .. The picture is quite diferent . Notice taht we have change ...
Cu les son las limitaciones de los nuevos antiagregantes? However, if we look at non CABG bleeding .. The picture is quite diferent . Notice taht we have change ...
| PowerPoint PPT presentation | free to download
Dietmar Trenk, PhD PowerPoint PPT Presentation
Dietmar Trenk, PhD - ... GER) D. A. Purdy (Rapid City, SD, US) D. Boese (Essen, GER) S. Puri (Moline, IL, US) H. Mudra (Munich, GER) K. Garatt (New York, NY, US) ...
... GER) D. A. Purdy (Rapid City, SD, US) D. Boese (Essen, GER) S. Puri (Moline, IL, US) H. Mudra (Munich, GER) K. Garatt (New York, NY, US) ...
| PowerPoint PPT presentation | free to download
Presentazione di PowerPoint PowerPoint PPT Presentation
Presentazione di PowerPoint - Title: Presentazione di PowerPoint Author: Osm Last modified by: Osm Created Date: 5/16/2005 2:33:51 PM Document presentation format: Presentazione su schermo
Title: Presentazione di PowerPoint Author: Osm Last modified by: Osm Created Date: 5/16/2005 2:33:51 PM Document presentation format: Presentazione su schermo
| PowerPoint PPT presentation | free to download
PowerPoint-Pr PowerPoint PPT Presentation
PowerPoint-Pr - Title: PowerPoint-Pr sentation Author: MD Last modified by: oem Created Date: 4/26/2004 8:35:39 PM Document presentation format: Bildschirmpr sentation
Title: PowerPoint-Pr sentation Author: MD Last modified by: oem Created Date: 4/26/2004 8:35:39 PM Document presentation format: Bildschirmpr sentation
| PowerPoint PPT presentation | free to view
Increased Risk of Ischemic Events PowerPoint PPT Presentation
Increased Risk of Ischemic Events - Title: No Slide Title Author: clint Last modified by: C. Michael Gibson Created Date: 12/1/2003 10:38:42 PM Document presentation format: On-screen Show (4:3)
Title: No Slide Title Author: clint Last modified by: C. Michael Gibson Created Date: 12/1/2003 10:38:42 PM Document presentation format: On-screen Show (4:3)
| PowerPoint PPT presentation | free to download
Primary End Point (CV death, MI and stroke at 15 months) PowerPoint PPT Presentation
Primary End Point (CV death, MI and stroke at 15 months) - Title: STEMI Author: GM Created Date: 6/17/2008 6:39:00 PM Document presentation format: On-screen Show (4:3) Company: PS Other titles: Arial MS P ...
Title: STEMI Author: GM Created Date: 6/17/2008 6:39:00 PM Document presentation format: On-screen Show (4:3) Company: PS Other titles: Arial MS P ...
| PowerPoint PPT presentation | free to download
Robert F. Storey PowerPoint PPT Presentation
Robert F. Storey - Stent thrombosis Future directions Robert F. Storey Senior Lecturer and Honorary Consultant in Cardiology, University of Sheffield, Sheffield, UK
Stent thrombosis Future directions Robert F. Storey Senior Lecturer and Honorary Consultant in Cardiology, University of Sheffield, Sheffield, UK
| PowerPoint PPT presentation | free to download
TRITON-TIM 38: Study design PowerPoint PPT Presentation
TRITON-TIM 38: Study design - TRITON-TIM 38: Study design. N = 13,608, moderate-to-high-risk ACS, scheduled for ... TRITON-TIMI 38 supports hypothesis that greater inhibition of platelet ...
TRITON-TIM 38: Study design. N = 13,608, moderate-to-high-risk ACS, scheduled for ... TRITON-TIMI 38 supports hypothesis that greater inhibition of platelet ...
| PowerPoint PPT presentation | free to view
ANTIPIASTRINICI E ANTICOAGULANTI NEI PAZIENTI CON SCA Quando come e perch PowerPoint PPT Presentation
ANTIPIASTRINICI E ANTICOAGULANTI NEI PAZIENTI CON SCA Quando come e perch - Title: CTO: who is the patient to treat ? Clinical indications to angioplasty Author: zoran olivari Last modified by: zolivari Created Date: 2/12/2012 9:37:04 AM
Title: CTO: who is the patient to treat ? Clinical indications to angioplasty Author: zoran olivari Last modified by: zolivari Created Date: 2/12/2012 9:37:04 AM
| PowerPoint PPT presentation | free to download
Nouveaut PowerPoint PPT Presentation
Nouveaut - Title: PowerPoint Presentation Created Date: 1/1/1601 12:00:00 AM Document presentation format: Affichage l' cran Other titles: Arial Times New Roman Verdana ...
Title: PowerPoint Presentation Created Date: 1/1/1601 12:00:00 AM Document presentation format: Affichage l' cran Other titles: Arial Times New Roman Verdana ...
| PowerPoint PPT presentation | free to download
Major Efficacy End Points in the PowerPoint PPT Presentation
Major Efficacy End Points in the - Title: Slide 1 Created Date: 11/14/2008 7:05:42 PM Document presentation format: On-screen Show (4:3) Other titles: Calibri Arial Times New Roman Office Theme Slide 1
Title: Slide 1 Created Date: 11/14/2008 7:05:42 PM Document presentation format: On-screen Show (4:3) Other titles: Calibri Arial Times New Roman Office Theme Slide 1
| PowerPoint PPT presentation | free to download
Update neue Thrombozytenaggregationshemmer PowerPoint PPT Presentation
Update neue Thrombozytenaggregationshemmer - Update neue Thrombozytenaggregationshemmer Wie soll die Haus rztin noch durchsteigen? G nther Egidi f r den H T 2014 mit Dank an Hans Wille *
Update neue Thrombozytenaggregationshemmer Wie soll die Haus rztin noch durchsteigen? G nther Egidi f r den H T 2014 mit Dank an Hans Wille *
| PowerPoint PPT presentation | free to download
Ask The Experts PowerPoint PPT Presentation
Ask The Experts - ... In Vitro Antiplatelet Effects of Active Metabolites in PRP ... their loading dose after ... that did not achieve statistical significance ...
... In Vitro Antiplatelet Effects of Active Metabolites in PRP ... their loading dose after ... that did not achieve statistical significance ...
| PowerPoint PPT presentation | free to download
AIDA STEMI PowerPoint PPT Presentation
AIDA STEMI - AIDA STEMI The abciximab intracoronary versus intravenously drug application in ST-elevation myocardial infarction (AIDA STEMI). Thiele H et al.
AIDA STEMI The abciximab intracoronary versus intravenously drug application in ST-elevation myocardial infarction (AIDA STEMI). Thiele H et al.
| PowerPoint PPT presentation | free to download
Diapositiva 1 PowerPoint PPT Presentation
Diapositiva 1 - Title: Diapositiva 1 Author: cardiologia Last modified by: Tekno Created Date: 9/17/2011 11:25:31 AM Document presentation format: Presentazione su schermo (4:3)
Title: Diapositiva 1 Author: cardiologia Last modified by: Tekno Created Date: 9/17/2011 11:25:31 AM Document presentation format: Presentazione su schermo (4:3)
| PowerPoint PPT presentation | free to download
Elliott M' Antman, MD Cardiovascular Division Brigham and Womens Hospital PowerPoint PPT Presentation
Elliott M' Antman, MD Cardiovascular Division Brigham and Womens Hospital - TRITON-TIMI 38 in perspective: Relative clinical safety and efficacy ... New development of STEMI. Outcome After MI: A Patient-Centered Perspective. Double-blind ...
TRITON-TIMI 38 in perspective: Relative clinical safety and efficacy ... New development of STEMI. Outcome After MI: A Patient-Centered Perspective. Double-blind ...
| PowerPoint PPT presentation | free to download
Folie 1 PowerPoint PPT Presentation
Folie 1 - Title: Folie 1 Author: xg09103 Last modified by: Luigi Oltrona Visconti Created Date: 1/2/2001 11:23:08 AM Document presentation format: Presentazione su schermo (4:3)
Title: Folie 1 Author: xg09103 Last modified by: Luigi Oltrona Visconti Created Date: 1/2/2001 11:23:08 AM Document presentation format: Presentazione su schermo (4:3)
| PowerPoint PPT presentation | free to download
Socialstyrelsens Nationella riktlinjer PowerPoint PPT Presentation
Socialstyrelsens Nationella riktlinjer - Title: Bild 1 Author: Kristina Eklund Last modified by: Egonsson Anna LK proc metod o pats ker Document presentation format: Bildspel p sk rmen (4:3)
Title: Bild 1 Author: Kristina Eklund Last modified by: Egonsson Anna LK proc metod o pats ker Document presentation format: Bildspel p sk rmen (4:3)
| PowerPoint PPT presentation | free to view
Gesundheitstraining   PowerPoint PPT Presentation
Gesundheitstraining - Title: Psychologische Schmerzbew ltigung Author: Dieter K ch Last modified by: Karin Meng Created Date: 8/18/2003 2:20:24 PM Document presentation format
Title: Psychologische Schmerzbew ltigung Author: Dieter K ch Last modified by: Karin Meng Created Date: 8/18/2003 2:20:24 PM Document presentation format
| PowerPoint PPT presentation | free to download
Diapositive 1 PowerPoint PPT Presentation
Diapositive 1 - Title: Diapositive 1 Author: Fran ois PESTY Last modified by: Fran ois PESTY Created Date: 10/16/2009 8:06:41 PM Document presentation format: Affichage l' cran
Title: Diapositive 1 Author: Fran ois PESTY Last modified by: Fran ois PESTY Created Date: 10/16/2009 8:06:41 PM Document presentation format: Affichage l' cran
| PowerPoint PPT presentation | free to download
En m PowerPoint PPT Presentation
En m - Title: En m decine on se doit Author: Philippe Last modified by: Philippe Created Date: 3/17/2011 5:18:59 PM Document presentation format: Affichage l' cran
Title: En m decine on se doit Author: Philippe Last modified by: Philippe Created Date: 3/17/2011 5:18:59 PM Document presentation format: Affichage l' cran
| PowerPoint PPT presentation | free to download
Antiplatelet Options for ACS: The Changing Landscape PowerPoint PPT Presentation
Antiplatelet Options for ACS: The Changing Landscape - UKEFF00106 July 2009. Prescribing information available in this presentation and upon request . UKEFF00106 July 2009. Prescribing information available in this ...
UKEFF00106 July 2009. Prescribing information available in this presentation and upon request . UKEFF00106 July 2009. Prescribing information available in this ...
| PowerPoint PPT presentation | free to download
Caso cl PowerPoint PPT Presentation
Caso cl - ... Rebote de eventos isqu micos (activaci n coagulaci n, suspensi n antitromb ticos) Efectos adversos de la hipotensi n y/o transfusiones NEJM 2006; ...
... Rebote de eventos isqu micos (activaci n coagulaci n, suspensi n antitromb ticos) Efectos adversos de la hipotensi n y/o transfusiones NEJM 2006; ...
| PowerPoint PPT presentation | free to view
Anti-thrombotiques aux urgences PowerPoint PPT Presentation
Anti-thrombotiques aux urgences - Title: Anti-vitamines K Anticoagulant oraux Warfarine (Coumadine ) Maladie du m lilot Mort aux rats Author: Schumi Last modified by: Schumi
Title: Anti-vitamines K Anticoagulant oraux Warfarine (Coumadine ) Maladie du m lilot Mort aux rats Author: Schumi Last modified by: Schumi
| PowerPoint PPT presentation | free to download
Antiplatelet drug resistance: Definitions, diagnosis, and implications for personalized medicine PowerPoint PPT Presentation
Antiplatelet drug resistance: Definitions, diagnosis, and implications for personalized medicine - Antiplatelet drug resistance: Definitions, diagnosis, and implications for personalized medicine Peter Berger, MD Interventional Cardiologist Director, Center for ...
Antiplatelet drug resistance: Definitions, diagnosis, and implications for personalized medicine Peter Berger, MD Interventional Cardiologist Director, Center for ...
| PowerPoint PPT presentation | free to view
What PowerPoint PPT Presentation
What - What s New in Acute Coronary Syndromes? Claudia Bucci BScPhm, PharmD Clinical Coordinator, Cardiovascular Diseases Sunnybrook Health Sciences Centre
What s New in Acute Coronary Syndromes? Claudia Bucci BScPhm, PharmD Clinical Coordinator, Cardiovascular Diseases Sunnybrook Health Sciences Centre
| PowerPoint PPT presentation | free to download
Ask The Experts PowerPoint PPT Presentation
Ask The Experts - Welcome Ask The Experts March 24-27, 2007 New Orleans, LA AntiPlatelet Therapy in ACS and PCI Stephen D. Wiviott, MD Associate Physician, Cardiovascular Division ...
Welcome Ask The Experts March 24-27, 2007 New Orleans, LA AntiPlatelet Therapy in ACS and PCI Stephen D. Wiviott, MD Associate Physician, Cardiovascular Division ...
| PowerPoint PPT presentation | free to download
Nuevos Antiagregantes, Monitorizaci PowerPoint PPT Presentation
Nuevos Antiagregantes, Monitorizaci - Title: Gui n Clases estudiantes Author: jordi bozzo Last modified by: Cele Ram rez Created Date: 3/9/1999 10:48:26 AM Document presentation format
Title: Gui n Clases estudiantes Author: jordi bozzo Last modified by: Cele Ram rez Created Date: 3/9/1999 10:48:26 AM Document presentation format
| PowerPoint PPT presentation | free to download
Challenging Case Presentations PowerPoint PPT Presentation
Challenging Case Presentations - Title: Slide 1 Author: DAngiolillo Last modified by: sgutch Created Date: 4/18/2005 2:58:16 PM Document presentation format: On-screen Show (4:3) Company
Title: Slide 1 Author: DAngiolillo Last modified by: sgutch Created Date: 4/18/2005 2:58:16 PM Document presentation format: On-screen Show (4:3) Company
| PowerPoint PPT presentation | free to download
Page of  


PowerPlugs
PowerPlugs
View by Category
Presentations
  • Photo Slideshows
  • Presentations (free-to-view)
    • Concepts & Trends
    • Entertainment
    • Fashion & Beauty
    • Government & Politics
    • How To, Education & Training
    • Medicine, Science & Technology
    • Other
    • Pets & Animals
    • Products & Services
    • Religious & Philosophical
    • Travel & Places
  • Presentations (pay-to-view)
Products Sold on our sister site CrystalGraphics.com
  • Ultimate Combo for PPT
  • PowerPoint Templates
  • Charts & Diagrams for PPT
  • 3D Character Slides
  • Background Videos for PPT
  • More Products for PPT
PowerPlugs
PowerPlugs
CrystalGraphics
Home About Us Terms and Conditions Privacy Policy Contact Us Send Us Feedback
Copyright 2021 CrystalGraphics, Inc. — All rights Reserved. PowerShow.com is a trademark of CrystalGraphics, Inc.
prasugrel — Search results on PowerShow.com
Loading...